Stellar Biotechnologies appoints two to board
Dr. Olson has been a member of Stellar's scientific advisory board since June 2014 and has extensive scientific, manufacturing and senior management experience in the biotechnology and pharmaceutical industries.
Dr. Olson is currently Chief Technology Officer at Anthera Pharmaceuticals, Inc. and is a Principal Biotechnology Consultant for Compass Biotechnology LLC.
Mr. Chun is Managing Partner and founder of Eldred Advisors LLC, an advisory firm specializing in the life sciences.
Mr. Chun brings broad experience as an investment analyst and strategic advisor to the Board, including expertise in therapeutics development and commercialization, corporate development, strategy and finance.
Mr. Chun's previous work includes roles at Goldman, Sachs & Co., Tavistock Life Sciences Co., Amgen, Inc., and Westwicke Partners, LLC. ■
LATEST MOVES FROM California
- CBRE Group appoints Beth F. Cobert to board
- Cloudera appoints two to board
- Verifone appoints Rowan Trollope to board of directors
- Catasys appoints Christopher Shirley as CFO
- Silicon Valley Bank promotes Michael Descheneaux to president
More inside POST
Sotheby's Q1 net loss $11.3 million Earnings